TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization
Article in Microbial Cell (June 2023)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in Microbial Cell (June 2023)
Article in Progress in Biophysics and Molecular Biology (January 2022)
Article in Scandinavian Journal of Gastroenterology (May 2021)